Format

Send to

Choose Destination
Arch Dermatol. 2007 Jun;143(6):779-82.

Systemic adjuvant therapy for patients with high-risk melanoma.

Author information

1
Department of Dermatology, Harvard Medical School, 55 Fruit St, Bartlett 616, Boston, MA 02114, USA. ktsai@partners.org
PMID:
17576946
DOI:
10.1001/archderm.143.6.779

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center